This page provides guidance and recommendations for the brain imaging services that should be provided to ALZ-NET participants. Resources include recommend training, acquisition protocols, scanner information, required sequences, and reporting guidelines and templates for Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI). For more information on image submission in ALZ-NET, visit Data Collection.
Note: All brain imaging procedures that ALZ-NET participants undergo are conducted per local practice, applicable procedure standards, appropriate use guidelines, and applicable FDA labels of Alzheimer’s disease therapies.
Participating ALZ-NET Imaging Facilities will receive discounted use of FDA-cleared AI products that aid in the clinical workflow of Alzheimer's disease diagnosis and treatment. Products include:
General PET Resources
Amyloid PET Resources
Tau PET Resources
FDA labels for Tau PET radiotracers:
Amyloid Related Imaging Abnormalities (ARIA) Management